Authors:
VALDENAIRE O
GILLER T
BREU V
ARDATI A
SCHWEIZER A
RICHARDS JG
Citation: O. Valdenaire et al., A NEW FAMILY OF ORPHAN G-PROTEIN-COUPLED RECEPTORS PREDOMINANTLY EXPRESSED IN THE BRAIN, FEBS letters, 424(3), 1998, pp. 193-196
Authors:
NEIDHART W
BREU V
BURRI K
CLOZEL M
HIRTH G
KLINKHAMMER U
GILLER T
RAMUZ H
Citation: W. Neidhart et al., DISCOVERY OF RO-48-5695 - A POTENT MIXED ENDOTHELIN RECEPTOR ANTAGONIST OPTIMIZED FROM BOSENTAN, Bioorganic & medicinal chemistry letters, 7(17), 1997, pp. 2223-2228
Authors:
VALDENAIRE O
GILLER T
BREU V
GOTTOWIK J
KILPATRICK G
Citation: O. Valdenaire et al., A NEW FUNCTIONAL ISOFORM OF THE HUMAN CRF2 RECEPTOR FOR CORTICOTROPIN-RELEASING FACTOR, Biochimica et biophysica acta, N. Gene structure and expression, 1352(2), 1997, pp. 129-132
Authors:
ROUX S
BREU V
GILLER T
NEIDHART W
RAMUZ H
COASSOLO P
CLOZEL JP
CLOZEL M
Citation: S. Roux et al., RO-61-1790, A NEW HYDROSOLUBLE ENDOTHELIN ANTAGONIST - GENERAL PHARMACOLOGY AND EFFECTS ON EXPERIMENTAL CEREBRAL VASOSPASM, The Journal of pharmacology and experimental therapeutics, 283(3), 1997, pp. 1110-1118
Authors:
MATHEWS S
DOBELI H
PRUSCHY M
BOSSER R
DARCY A
OEFNER C
ZULAUF M
GENTZ R
BREU V
MATILE H
SCHLAEGER J
FISCHLI W
Citation: S. Mathews et al., RECOMBINANT HUMAN RENIN PRODUCED IN DIFFERENT EXPRESSION SYSTEMS - BIOCHEMICAL-PROPERTIES AND 3D STRUCTURE, Protein expression and purification, 7(1), 1996, pp. 81-91
Authors:
DAGASSAN PH
BREU V
CLOZEL M
KUNZLI A
VOGT P
TURINA M
KIOWSKI W
CLOZEL JP
Citation: Ph. Dagassan et al., UP-REGULATION OF ENDOTHELIN-B RECEPTORS IN ATHEROSCLEROTIC HUMAN CORONARY-ARTERIES, Journal of cardiovascular pharmacology, 27(1), 1996, pp. 147-153
Authors:
ZUCCARELLO M
SOATTIN GB
LEWIS AI
BREU V
HALLAK H
RAPOPORT RM
Citation: M. Zuccarello et al., PREVENTION OF SUBARACHNOID HEMORRHAGE-INDUCED CEREBRAL VASOSPASM BY ORAL-ADMINISTRATION OF ENDOTHELIN RECEPTOR ANTAGONISTS, Journal of neurosurgery, 84(3), 1996, pp. 503-507
Authors:
BREU V
CLOZEL M
BURRI K
HIRTH G
NEIDHART W
RAMUZ H
Citation: V. Breu et al., IN-VITRO CHARACTERIZATION OF RO-46-8443, THE FIRST NONPEPTIDE ANTAGONIST SELECTIVE FOR THE ENDOTHELIN ET(B) RECEPTOR, FEBS letters, 383(1-2), 1996, pp. 37-41
Citation: M. Clozel et V. Breu, THE ROLE OF ET(B) RECEPTORS IN NORMOTENSIVE AND HYPERTENSIVE RATS AS REVEALED BY THE NONPEPTIDE SELECTIVE ET(B) RECEPTOR ANTAGONIST RO-46-8443, FEBS letters, 383(1-2), 1996, pp. 42-45
Citation: Ma. Mcauley et al., THE EFFECTS OF BOSENTAN ON CEREBRAL BLOOD-FLOW AND HISTOPATHOLOGY FOLLOWING MIDDLE CEREBRAL-ARTERY OCCLUSION IN THE RAT, European journal of pharmacology, 307(2), 1996, pp. 171-181
Authors:
PIESKE B
BEYERMANN B
DUIS J
CLOZEL M
BREU V
Citation: B. Pieske et al., ENDOTHELIN-1 INCREASES CONTRACTILITY IN HUMAN DILATED CARDIOMYOPATHY VIA AN UP-REGULATED ET-A RECEPTOR SUBTYPE, Circulation, 94(8), 1996, pp. 2363-2363
Citation: Ga. Gray et al., ENDOTHELIN RECEPTORS THAT MODULATE CONTRACTION OF THE RAT FUNDUS, Journal of cardiovascular pharmacology, 26, 1995, pp. 126-129
Citation: Ph. Dagassan et al., ROLE OF ENDOTHELIN IN SPONTANEOUS PHASIC CONTRACTION OF HUMAN CORONARY-ARTERIES, Journal of cardiovascular pharmacology, 26, 1995, pp. 200-203
Authors:
BREU V
HASHIDO K
BROGER C
MIYAMOTO C
FURUICHI Y
HAYES A
KALINA B
LOFFLER BM
RAMUZ H
CLOZEL M
Citation: V. Breu et al., SEPARABLE BINDING-SITES FOR THE NATURAL AGONIST ENDOTHELIN-1 AND THE NONPEPTIDE ANTAGONIST BOSENTAN ON HUMAN ENDOTHELIN-A RECEPTORS, European journal of biochemistry, 231(1), 1995, pp. 266-270
Authors:
FISCHLI W
CLOZEL JP
BREU V
BUCHMANN S
MATHEWS S
STADLER H
VIEIRA E
WOSTL W
Citation: W. Fischli et al., CIPROKIREN (RO-44-9375) - A RENIN INHIBITOR WITH INCREASING EFFECTS ON CHRONIC TREATMENT, Hypertension, 24(2), 1994, pp. 163-169
Citation: Ph. Dagassan et al., ROLE OF ENDOTHELIN DURING REPERFUSION AFTER ISCHEMIA IN ISOLATED-PERFUSED RAT-HEART, Journal of cardiovascular pharmacology, 24(6), 1994, pp. 867-874
Authors:
CLOZEL JP
HESS P
SCHIETINGER K
BREU V
FISCHLI W
BAUMGARTNER HR
Citation: Jp. Clozel et al., MAJOR ROLE OF THE RENIN-ANGIOTENSIN SYSTEM IN THE NEOINTIMA FORMATIONAFTER VASCULAR INJURY IN GUINEA-PIGS, Life sciences, 54(6), 1994, pp. 87-92
Authors:
CLOZEL M
BREU V
GRAY GA
KALINA B
LOFFLER BM
BURRI K
CASSAL JM
HIRTH G
MULLER M
NEIDHART W
RAMUZ H
Citation: M. Clozel et al., PHARMACOLOGICAL CHARACTERIZATION OF BOSENTAN, A NEW POTENT ORALLY-ACTIVE NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST, The Journal of pharmacology and experimental therapeutics, 270(1), 1994, pp. 228-235
Authors:
TEERLINK JR
BREU V
SPRECHER U
CLOZEL M
CLOZEL JP
Citation: Jr. Teerlink et al., POTENT VASOCONSTRICTION MEDIATED BY ENDOTHELIN ET(B) RECEPTORS IN CANINE CORONARY-ARTERIES, Circulation research, 74(1), 1994, pp. 105-114
Citation: M. Clozel et al., IN-VIVO PHARMACOLOGY OF RO 46-2005, THE 1ST SYNTHETIC NONPEPTIDE ENDOTHELIN RECEPTOR ANTAGONIST - IMPLICATIONS FOR ENDOTHELIN PHYSIOLOGY, Journal of cardiovascular pharmacology, 22, 1993, pp. 190000377-190000379
Authors:
CLOZEL M
BREU V
BURRI K
CASSAL JM
FISCHLI W
GRAY GA
HIRTH G
LOFFLER BM
MULLER M
NEIDHART W
RAMUZ H
Citation: M. Clozel et al., PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN REVEALED BY THE 1ST ORALLY-ACTIVE ENDOTHELIN RECEPTOR ANTAGONIST, Nature, 365(6448), 1993, pp. 759-761
Citation: V. Breu et al., IN-VITRO CHARACTERIZATION OF RO 46-2005, A NOVEL SYNTHETIC NONPEPTIDEENDOTHELIN ANTAGONIST OF ET(A) AND ET(B) RECEPTORS, FEBS letters, 334(2), 1993, pp. 210-214